The Chancellor, Masters, Scholars Of The University Of Oxford investment portfolio

BRILL POWER LIMITED develops intelligent battery management systems and a Battery Intelligence Platform to enhance the performance, safety, and lifespan of lithium-ion and sodium-ion batteries. Their products and services target stationary energy storage for residential, commercial, industrial, and grid-scale applications, as well as electric vehicles and marine energy storage.

OMass Therapeutics develops proprietary high‑resolution mass‑spectrometry platforms to discover novel medicines by analysing intact protein assemblies, enabling identification of drug leads that modulate complex formation. It provides these drug‑discovery technologies to programs targeting complex and membrane‑protein targets to address unmet medical needs.